QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 260 filers reported holding QIAGEN NV in Q1 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $415,000 | -75.1% | 8,477 | -71.8% | 0.01% | -52.0% |
| Q4 2021 | $1,668,000 | +99.3% | 30,011 | +85.2% | 0.02% | +25.0% |
| Q3 2021 | $837,000 | +48.1% | 16,208 | +38.6% | 0.02% | +100.0% |
| Q2 2021 | $565,000 | -30.6% | 11,693 | -30.1% | 0.01% | -41.2% |
| Q1 2021 | $814,000 | +27.6% | 16,718 | +38.7% | 0.02% | 0.0% |
| Q4 2020 | $638,000 | -6.3% | 12,054 | -7.4% | 0.02% | 0.0% |
| Q3 2020 | $681,000 | -80.0% | 13,016 | -83.6% | 0.02% | -71.2% |
| Q2 2020 | $3,402,000 | +76.7% | 79,454 | +39.5% | 0.06% | +103.4% |
| Q4 2019 | $1,925,000 | +325.9% | 56,954 | +315.7% | 0.03% | +222.2% |
| Q3 2019 | $452,000 | +39.1% | 13,700 | +60.0% | 0.01% | +50.0% |
| Q3 2018 | $325,000 | +57.0% | 8,565 | +49.6% | 0.01% | +50.0% |
| Q2 2018 | $207,000 | -47.6% | 5,727 | -53.2% | 0.00% | -33.3% |
| Q1 2018 | $395,000 | -70.5% | 12,246 | -69.4% | 0.01% | -62.5% |
| Q2 2017 | $1,340,000 | – | 39,987 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |